Richard A. Henson Cancer Institute at Peninsula Regional Medical Center Receives Third Susan G. Komen Grant for Clinical Research
The Richard A. Henson Cancer Institute at Peninsula Regional Medical Center (PRMC) is once again the recipient of a grant from the Maryland Affiliate of Susan G. Komen for the Cure, a global organization dedicated to finding a cure for breast cancer. One of only three recipients of a Clinical Trial Enrollment (CTE) grant in the state of Maryland, the Richard A. Henson Cancer Institute has been awarded $85,000 to assist with clinical trial outreach efforts for breast cancer patients on Maryland’s Eastern Shore.
Under the leadership of Bennett Yu, MD, Director of Oncology Clinical Research, and Sandy Heineken, RN, Program Coordinator, the grant achieved the third consecutive year of successful funding. Joan M. Daugherty, Executive Director of the Henson Cancer Institute, accepted the grant on behalf of Peninsula Regional at the third annual Komen Grant Award Event, held at the Reginald F. Lewis Museum in Baltimore on April 3, 2012.
The Richard A. Henson Cancer Institute will maintain its grant focus to improve public and professional awareness of breast cancer clinical trials, increase understanding about the decision-making process of patients considering participation in clinical trials, and bolster participation of minority patients in breast cancer trials at Peninsula Regional. Funding has been increased by $10,000 this year to offset travel expenses incurred by breast cancer patients who are enrolled in a clinical trial, many of whom travel significant distances to come to the cancer institute.
The main accomplishments of the past year’s grant-sponsored activity have been the successful outreach to 380 lay persons and 81 medical professionals, the opening of three new breast cancer clinical trials, and the enrollment of 13 patients onto a National Cancer Institute-sponsored breast cancer clinical trial, of which three are African-American. Achieving better participation levels in clinical trials is critical to making progress in preventing, detecting, and treating breast cancer. Only an estimated 3-5% of all cancer patients elect to participate in a clinical trial as a part of their treatment, further justifying the urgent need for Maryland women and their families to be aware of breast cancer clinical trials and organizations like the Richard A. Henson Cancer Institute and Susan G. Komen for the Cure that continue to fight for the cure.
Komen Maryland grants support a variety of innovative programs that offer a comprehensive range of breast health services, including screenings, community education and outreach, treatment and support, provider education and clinical trial recruitment. Peninsula Regional Medical Center remains grateful for the support and encouragement given to it by the Komen Maryland Affiliate.